Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Return on Capital Employed (2016 - 2025)

Mimedx (MDXG) has disclosed Return on Capital Employed for 14 consecutive years, with 0.24% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 4.0% to 0.24% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.24% through Dec 2025, down 4.0% year-over-year, with the annual reading at 0.27% for FY2025, 2.0% down from the prior year.
  • Return on Capital Employed hit 0.24% in Q4 2025 for Mimedx, up from 0.22% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.34% in Q2 2024 to a low of 0.27% in Q1 2021.
  • Historically, Return on Capital Employed has averaged 0.07% across 5 years, with a median of 0.15% in 2025.
  • Biggest five-year swings in Return on Capital Employed: soared 44bps in 2023 and later decreased -15bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.05% in 2021, then crashed by -130bps to 0.11% in 2022, then surged by 293bps to 0.22% in 2023, then grew by 28bps to 0.28% in 2024, then fell by -15bps to 0.24% in 2025.
  • Business Quant data shows Return on Capital Employed for MDXG at 0.24% in Q4 2025, 0.22% in Q3 2025, and 0.19% in Q2 2025.